These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17338640)

  • 1. Specific inhibition of interleukin-13 activity by a recombinant human single-chain immunoglobulin domain directed against the IL-13 receptor alpha1 chain.
    Knackmuss S; Krause S; Engel K; Reusch U; Virchow JC; Mueller T; Kraich M; Little M; Luttmann W; Friedrich K
    Biol Chem; 2007 Mar; 388(3):325-30. PubMed ID: 17338640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
    Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
    Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
    Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
    Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interleukin-13 receptor alpha 1-subunit on peripheral blood eosinophils is regulated by cytokines.
    Myrtek D; Knoll M; Matthiesen T; Krause S; Lohrmann J; Schillinger D; Idzko M; Virchow JC; Friedrich K; Luttmann W
    Immunology; 2004 Aug; 112(4):597-604. PubMed ID: 15270731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression.
    Kaur D; Hollins F; Woodman L; Yang W; Monk P; May R; Bradding P; Brightling CE
    Allergy; 2006 Sep; 61(9):1047-53. PubMed ID: 16918506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the extracellular region of the human interleukin-4 receptor alpha chain and interleukin-13 receptor alpha1 chain by a silkworm-baculovirus system.
    Honjo E; Shoyama Y; Tamada T; Shigematsu H; Hatanaka T; Kanaji S; Arima K; Ito Y; Izuhara K; Kuroki R
    Protein Expr Purif; 2008 Jul; 60(1):25-30. PubMed ID: 18467124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
    Kuznetsov VA; Puri RK
    Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
    Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
    Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a functional IL-13Ralpha1 by rat B cells.
    Pierrot C; Beniguel L; Bègue A; Khalife J
    Biochem Biophys Res Commun; 2001 Oct; 287(4):969-76. PubMed ID: 11573960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.
    Kioi M; Kawakami K; Puri RK
    Cell Immunol; 2004 May; 229(1):41-51. PubMed ID: 15331327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IL-13 receptor alpha 1 expression and signaling on human tonsillar B-lymphocyte subsets.
    Hajoui O; Zheng H; Guay J; Letuve S; Fawaz LM; Mazer BD
    J Allergy Clin Immunol; 2007 Dec; 120(6):1425-32. PubMed ID: 17761275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
    Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
    Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle IL-4, IL-4Ralpha, IL-13 and IL-13Ralpha1 expression and response to strength training.
    Prokopchuk O; Liu Y; Wang L; Wirth K; Schmidtbleicher D; Steinacker JM
    Exerc Immunol Rev; 2007; 13():67-75. PubMed ID: 18198661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.
    Joshi BH; Hogaboam C; Dover P; Husain SR; Puri RK
    Vitam Horm; 2006; 74():479-504. PubMed ID: 17027527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization property of interleukin-4 receptor alpha chain increases cytotoxic effect of interleukin-4 receptor-targeted cytotoxin in cancer cells.
    Kawakami K; Kawakami M; Leland P; Puri RK
    Clin Cancer Res; 2002 Jan; 8(1):258-66. PubMed ID: 11801567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding characterization of the interleukin-13 signaling complex and development of a ternary time-resolved fluorescence resonance energy transfer assay.
    Yang X; Lee J; Brooks J; Wilhelm J; Myszka D; Kasaian MT; Goldman S; Wolf S; Fitz LJ
    Anal Biochem; 2008 May; 376(2):206-12. PubMed ID: 18328249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.
    Joshi BH; Leland P; Puri RK
    Croat Med J; 2003 Aug; 44(4):455-62. PubMed ID: 12950150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: the A-549 cell bioassay.
    Miller R; Sadhukhan R; Wu C
    J Immunol Methods; 2008 May; 334(1-2):134-41. PubMed ID: 18355834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
    Chen L; Liu Y; Hou Y; Kato Y; Sano H; Kanno T
    Neurosci Lett; 2007 Apr; 417(1):30-5. PubMed ID: 17398005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potent antagonist antibodies against mouse IL-13Rα1 using novel bioassays.
    Edwards KM; Huynh H; Prasad R; McDonald A; Hardy MP; Scotney P; Owczarek CM; Busfield SJ; Panousis C; Wilson NJ
    J Immunol Methods; 2014 May; 407():48-57. PubMed ID: 24704819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.